
08/10/2024
Breaking: The first gene therapy for ALS, QALSODY, has been approved today in China.
QALSODY (tofersen) is a prescription medicine used to treat adults with amyotrophic lateral sclerosis (ALS) who have a mutation, or change, in the superoxide dismutase 1 (SOD1) gene. This innovative medicine was approved by the US FDA in 2023, it is approved today by the China NMPA, and soon will be available in hospitals in the country.